Related Experiment Videos
Gastric cytoprotection.
1Department of Pharmacology, Goa Medical College, Tiswadi.
Indian Journal of Physiology and Pharmacology
|April 1, 1991
Summary
Cytoprotection protects the gastric lining from injury through mechanisms beyond acid reduction. This includes enhanced mucus production and improved mucosal blood flow, with several drugs showing protective effects.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Gastric mucosal injury is a significant clinical concern.
- Traditional treatments focus on acid suppression.
- Cytoprotection offers an alternative therapeutic strategy.
Purpose of the Study:
- To define and explore the concept of gastric cytoprotection.
- To review proposed mechanisms of cytoprotection.
- To identify drugs with demonstrated cytoprotective properties.
Main Methods:
- Review of proposed cytoprotective mechanisms.
- Identification of drugs with cytoprotective actions in animal models.
- Analysis of therapeutic agents for peptic ulcer disease.
Main Results:
- Cytoprotection involves mechanisms like increased mucus and bicarbonate secretion, enhanced mucosal blood flow, and free radical scavenging.
- Drugs such as sucralfate, colloidal bismuth, and aluminum antacids exhibit cytoprotective effects.
- Additional agents like zinc sulfate, meciadanol, propranolol, and dipyridamole also show cytoprotective potential.
Conclusions:
- Gastric cytoprotection represents a distinct and increasingly recognized approach to managing gastric mucosal injury.
- A growing number of therapeutic agents possess cytoprotective capabilities, expanding treatment options.